|Minimum Order Quantity||500 Bottle|
|Packaging Size||40 CAPSULE|
Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.
The drug was developed at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE). It was then acquired by Miami-based company Ridgeback Biotherapeutics, who later partnered with Merck & Co. to develop the drug further
|Packaging Size||90 Capsule|
|Composition||Pantosan Polysulfate Sodium|
|Manufacturer||Swati Spentose Pvt Ltd|
|Treatment||Tacrolimus is used with other medications to prevent rejection of a kidney, heart, liver, or lung tr|
Tacrolimus is used with other medications to prevent rejection of a kidney, heart, liver, or lung transplant. This medication belongs to a class of drugs known as immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own.